DNAH9
Basic information
Region (hg38): 17:11598470-11969748
Previous symbols: [ "DNAH17L" ]
Links
Phenotypes
GenCC
Source:
- ciliary dyskinesia, primary, 40 (Strong), mode of inheritance: AR
- ciliary dyskinesia, primary, 40 (Moderate), mode of inheritance: AR
- primary ciliary dyskinesia (Supportive), mode of inheritance: AD
- situs inversus (Supportive), mode of inheritance: AD
- schizophrenia (Limited), mode of inheritance: AD
- ciliary dyskinesia, primary, 40 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Ciliary dyskinesia, primary, 40 | AR | Allergy/Immunology/Infectious; Audiologic/Otolaryngologic; Cardiovascular; Pulmonary | Individuals have been described with a relatively mild respiratory phenotype, but awareness may allow early diagnosis and prompt management of infections and related respiratory sequelae; Individuals may require surgery or other interventions related to congenital cardiac malformations | Allergy/Immunology/Infectious; Cardiovascular; Gastrointestinal; Pulmonary | 30471717; 30471718 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (53 variants)
- Ciliary dyskinesia, primary, 40 (3 variants)
- Congenital heart disease (2 variants)
- Non-immune hydrops fetalis (1 variants)
- DNAH9-related disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DNAH9 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 389 | 43 | 435 | |||
missense | 666 | 34 | 42 | 743 | ||
nonsense | 29 | 40 | ||||
start loss | 2 | |||||
frameshift | 22 | 31 | ||||
inframe indel | 9 | |||||
splice donor/acceptor (+/-2bp) | 26 | 30 | ||||
splice region | 1 | 22 | 51 | 4 | 78 | |
non coding | 165 | 139 | 311 | |||
Total | 55 | 43 | 689 | 589 | 225 |
Highest pathogenic variant AF is 0.000197
Variants in DNAH9
This is a list of pathogenic ClinVar variants found in the DNAH9 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-11598497-C-T | DNAH9-related disorder | Benign (Jun 18, 2019) | ||
17-11598500-TGCGGCTCGCGGAGGAGCGGGCCGCGCTC-T | Pathogenic (Jun 17, 2023) | |||
17-11598501-G-A | Uncertain significance (Sep 17, 2021) | |||
17-11598503-GGCTCGCGGAGGAGCGGGCCGC-G | Uncertain significance (Aug 23, 2022) | |||
17-11598505-C-G | Uncertain significance (Sep 06, 2023) | |||
17-11598505-C-T | Uncertain significance (Nov 29, 2022) | |||
17-11598513-G-A | Likely benign (Jul 26, 2022) | |||
17-11598517-CGGGCCGCGCTCGCGGCGGAGAA-AACGCGGATGGGGAACCCGGCGCCGAC | Pathogenic (May 19, 2022) | |||
17-11598522-C-G | Likely benign (May 27, 2022) | |||
17-11598522-C-T | Likely benign (May 24, 2022) | |||
17-11598525-G-T | DNAH9-related disorder | Likely benign (Apr 26, 2021) | ||
17-11598528-C-T | Likely benign (Nov 04, 2023) | |||
17-11598537-G-C | Inborn genetic diseases • Ciliary dyskinesia, primary, 40 | Uncertain significance (Nov 19, 2022) | ||
17-11598540-C-G | Inborn genetic diseases • DNAH9-related disorder | Conflicting classifications of pathogenicity (Jan 20, 2024) | ||
17-11598539-A-ACGCGGATGGGGAACCCGGCGCCGAC | DNAH9-related disorder | Benign (Jan 31, 2024) | ||
17-11598543-G-A | Likely benign (Nov 10, 2023) | |||
17-11598554-C-G | Inborn genetic diseases | Uncertain significance (May 12, 2024) | ||
17-11598558-C-A | Likely benign (Aug 10, 2023) | |||
17-11598558-C-T | Likely benign (Jun 09, 2023) | |||
17-11598559-G-T | Inborn genetic diseases | Uncertain significance (Jan 08, 2024) | ||
17-11598567-A-C | DNAH9-related disorder | Benign (Dec 17, 2023) | ||
17-11598568-C-G | Inborn genetic diseases | Uncertain significance (Dec 18, 2023) | ||
17-11598568-C-T | Pathogenic (May 27, 2023) | |||
17-11598569-G-A | Uncertain significance (May 18, 2023) | |||
17-11598570-A-C | Likely benign (Jan 02, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DNAH9 | protein_coding | protein_coding | ENST00000262442 | 69 | 371318 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.05e-60 | 1.00 | 125231 | 0 | 517 | 125748 | 0.00206 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0429 | 2436 | 2.43e+3 | 1.00 | 0.000139 | 29535 |
Missense in Polyphen | 660 | 714.46 | 0.92377 | 8620 | ||
Synonymous | 0.640 | 920 | 945 | 0.974 | 0.0000555 | 8660 |
Loss of Function | 5.03 | 130 | 208 | 0.624 | 0.0000106 | 2429 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00421 | 0.00421 |
Ashkenazi Jewish | 0.000893 | 0.000893 |
East Asian | 0.00398 | 0.00398 |
Finnish | 0.00153 | 0.00153 |
European (Non-Finnish) | 0.00194 | 0.00192 |
Middle Eastern | 0.00398 | 0.00398 |
South Asian | 0.00232 | 0.00232 |
Other | 0.000979 | 0.000978 |
dbNSFP
Source:
- Function
- FUNCTION: Force generating protein of respiratory cilia. Produces force towards the minus ends of microtubules. Dynein has ATPase activity; the force-producing power stroke is thought to occur on release of ADP.;
- Pathway
- Huntington,s disease - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.119
Intolerance Scores
- loftool
- 0.964
- rvis_EVS
- 0.46
- rvis_percentile_EVS
- 78.06
Haploinsufficiency Scores
- pHI
- 0.210
- hipred
- Y
- hipred_score
- 0.593
- ghis
- 0.413
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.544
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Dnah9
- Phenotype
Gene ontology
- Biological process
- microtubule-based movement;cell projection organization
- Cellular component
- microtubule;axoneme;dynein complex;9+2 motile cilium;distal portion of axoneme
- Molecular function
- ATP binding;ATP-dependent microtubule motor activity, minus-end-directed;dynein light chain binding;dynein intermediate chain binding;dynein light intermediate chain binding